Alan Liss, Ph.D.
Dr. Liss has over 30 years of experience in the vaccine, biologics, and pharmaceutical product development and manufacturing. Dr. Liss recently retired from FDA where he directed the Public Health and Security Action Team Program which enhanced the FDA approval process for medical countermeasure (MCM) candidates. Prior to joining FDA, Dr. Liss’s work on furthering MCM development included his helping to stand-up the Regulatory and Quality Affairs Division of the Biomedical Advanced Research and Development Authority (BARDA). Prior to joining the government, Dr. Liss designed and executed effective U.S. and global quality and regulatory strategies to support both pharmaceutical and biopharmaceutical development programs. He received a Bachelor’s degree in Genetics from the University of California, Berkeley, and his Ph.D. in Microbiology and Immunology from the University of Rochester, School of Medicine and Dentistry.